Shares of Vital Therapies (NASDAQ:VTL) gapped up before the market opened on Monday . The stock had previously closed at $0.50, but opened at $0.77. Vital Therapies shares last traded at $0.83, with a volume of 86513466 shares.
Separately, ValuEngine upgraded shares of Vital Therapies from a “hold” rating to a “buy” rating in a report on Thursday, April 4th. Six analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Vital Therapies currently has a consensus rating of “Hold” and an average target price of $12.00.
Vital Therapies (NASDAQ:VTL) last posted its quarterly earnings data on Monday, March 4th. The company reported ($0.06) earnings per share for the quarter.
Several large investors have recently bought and sold shares of VTL. Geode Capital Management LLC boosted its position in Vital Therapies by 99.7% in the 4th quarter. Geode Capital Management LLC now owns 682,934 shares of the company’s stock valued at $127,000 after buying an additional 340,970 shares during the period. Two Sigma Investments LP boosted its position in Vital Therapies by 42.5% in the 4th quarter. Two Sigma Investments LP now owns 208,872 shares of the company’s stock valued at $39,000 after buying an additional 62,284 shares during the period. SG Americas Securities LLC purchased a new position in Vital Therapies in the 4th quarter valued at approximately $37,000. Virtu Financial LLC boosted its position in Vital Therapies by 120.3% in the 4th quarter. Virtu Financial LLC now owns 310,499 shares of the company’s stock valued at $58,000 after buying an additional 169,530 shares during the period. Finally, Vanguard Group Inc boosted its position in Vital Therapies by 11.1% in the 3rd quarter. Vanguard Group Inc now owns 1,481,908 shares of the company’s stock valued at $408,000 after buying an additional 148,016 shares during the period. 15.52% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “Vital Therapies (VTL) Shares Gap Up to $0.77” was reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://www.baseballdailydigest.com/news/2019/04/15/vital-therapies-vtl-shares-gap-up-to-0-77.html.
Vital Therapies Company Profile (NASDAQ:VTL)
Vital Therapies, Inc, a biotherapeutic company, focuses on developing cell-based therapies for the treatment of acute forms of liver failure. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc in June 2003. Vital Therapies, Inc was founded in 2003 and is based in San Diego, California.
See Also: Understanding Specialty Certificates of Deposit
Receive News & Ratings for Vital Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vital Therapies and related companies with MarketBeat.com's FREE daily email newsletter.